ID   LIPG_RAT                Reviewed;         493 AA.
AC   Q8VBX1; Q5D216;
DT   26-JUL-2002, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 2.
DT   29-MAY-2024, entry version 140.
DE   RecName: Full=Endothelial lipase;
DE            EC=3.1.1.3 {ECO:0000250|UniProtKB:Q9Y5X9};
DE   AltName: Full=Endothelial-derived lipase;
DE            Short=EDL;
DE   AltName: Full=Phospholipase A1;
DE            EC=3.1.1.32 {ECO:0000250|UniProtKB:Q9Y5X9};
DE   Flags: Precursor;
GN   Name=Lipg;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Aortic smooth muscle;
RX   PubMed=15914124; DOI=10.1016/j.cardiores.2005.01.013;
RA   Shimokawa Y., Hirata K., Ishida T., Kojima Y., Inoue N., Quertermous T.,
RA   Yokoyama M.;
RT   "Increased expression of endothelial lipase in rat models of
RT   hypertension.";
RL   Cardiovasc. Res. 66:594-600(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 214-293.
RC   STRAIN=BN-Lx/Cub, and SHR/OlaIpcv;
RX   PubMed=11924532; DOI=10.3109/10425170109025004;
RA   Bonne A.C.M., den Bieman M.G., van Lith H., van Zutphen B.F.M.;
RT   "Sequencing and chromosomal assignment of the rat endothelial-derived
RT   lipase gene (Lipg).";
RL   DNA Seq. 12:285-287(2001).
CC   -!- FUNCTION: Exerts both phospholipase and triglyceride lipase activities
CC       (By similarity). More active as a phospholipase than a triglyceride
CC       lipase (By similarity). Hydrolyzes triglycerides, both with short-chain
CC       fatty acyl groups (tributyrin) and long-chain fatty acyl groups
CC       (triolein) with similar levels of activity toward both types of
CC       substrates (By similarity). Hydrolyzes high density lipoproteins (HDL)
CC       more efficiently than other lipoproteins (By similarity).
CC       {ECO:0000250|UniProtKB:Q9Y5X9}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a triacylglycerol + H2O = a diacylglycerol + a fatty acid +
CC         H(+); Xref=Rhea:RHEA:12044, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17855, ChEBI:CHEBI:18035, ChEBI:CHEBI:28868; EC=3.1.1.3;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y5X9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 2-acyl-sn-
CC         glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:18689,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:57643, ChEBI:CHEBI:57875; EC=3.1.1.32;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y5X9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z-octadecenoyl)-glycerol + H2O = (9Z)-
CC         octadecenoate + di-(9Z)-octadecenoylglycerol + H(+);
CC         Xref=Rhea:RHEA:38575, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:53753, ChEBI:CHEBI:75945;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y5X9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38576;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y5X9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tributanoylglycerol + H2O = butanoate +
CC         dibutanoylglycerol + H(+); Xref=Rhea:RHEA:40475, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17968, ChEBI:CHEBI:35020,
CC         ChEBI:CHEBI:76478; Evidence={ECO:0000250|UniProtKB:Q9Y5X9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40476;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y5X9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + H2O = H(+) +
CC         hexadecanoate + hexadecanoyl-sn-glycero-3-phosphocholine;
CC         Xref=Rhea:RHEA:41384, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:64563, ChEBI:CHEBI:72999;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y5X9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41385;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y5X9};
CC   -!- SUBUNIT: Head to tail Homodimer. Interacts with apolipoprotein C-2 (By
CC       similarity). {ECO:0000250|UniProtKB:Q9Y5X9}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:Q9Y5X9}.
CC   -!- MISCELLANEOUS: It is termed endothelial lipase due to the fact that it
CC       is synthesized in endothelial cells, a characteristic that
CC       distinguishes it from other members of the family. However, this
CC       protein is also expressed in other cell types.
CC   -!- SIMILARITY: Belongs to the AB hydrolase superfamily. Lipase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY916123; AAX11354.1; -; mRNA.
DR   EMBL; AY027561; AAK14774.1; -; Genomic_DNA.
DR   EMBL; AY027562; AAK14775.1; -; Genomic_DNA.
DR   RefSeq; NP_001012759.1; NM_001012741.1.
DR   AlphaFoldDB; Q8VBX1; -.
DR   SMR; Q8VBX1; -.
DR   STRING; 10116.ENSRNOP00000025257; -.
DR   BindingDB; Q8VBX1; -.
DR   ChEMBL; CHEMBL3638354; -.
DR   ESTHER; ratno-q5d216; Lipoprotein_Lipase.
DR   GlyCosmos; Q8VBX1; 3 sites, No reported glycans.
DR   GlyGen; Q8VBX1; 3 sites.
DR   PhosphoSitePlus; Q8VBX1; -.
DR   PaxDb; 10116-ENSRNOP00000025257; -.
DR   Ensembl; ENSRNOT00000025257.7; ENSRNOP00000025257.5; ENSRNOG00000018694.7.
DR   Ensembl; ENSRNOT00055017907; ENSRNOP00055014420; ENSRNOG00055010572.
DR   Ensembl; ENSRNOT00060015138; ENSRNOP00060011763; ENSRNOG00060009029.
DR   Ensembl; ENSRNOT00065038840; ENSRNOP00065031500; ENSRNOG00065022748.
DR   GeneID; 291437; -.
DR   KEGG; rno:291437; -.
DR   AGR; RGD:1310740; -.
DR   CTD; 9388; -.
DR   RGD; 1310740; Lipg.
DR   eggNOG; ENOG502QU8P; Eukaryota.
DR   GeneTree; ENSGT00940000159394; -.
DR   HOGENOM; CLU_027171_1_2_1; -.
DR   InParanoid; Q8VBX1; -.
DR   OMA; QMPVGHV; -.
DR   OrthoDB; 3428256at2759; -.
DR   PhylomeDB; Q8VBX1; -.
DR   TreeFam; TF324997; -.
DR   Reactome; R-RNO-8964058; HDL remodeling.
DR   PRO; PR:Q8VBX1; -.
DR   Proteomes; UP000002494; Chromosome 18.
DR   Bgee; ENSRNOG00000018694; Expressed in ovary and 14 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0052740; F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004465; F:lipoprotein lipase activity; IBA:GO_Central.
DR   GO; GO:0052739; F:phosphatidylserine 1-acylhydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008970; F:phospholipase A1 activity; ISS:UniProtKB.
DR   GO; GO:0004620; F:phospholipase activity; ISO:RGD.
DR   GO; GO:0004806; F:triglyceride lipase activity; ISS:UniProtKB.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISO:RGD.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0034375; P:high-density lipoprotein particle remodeling; ISO:RGD.
DR   GO; GO:0055091; P:phospholipid homeostasis; ISO:RGD.
DR   GO; GO:0032376; P:positive regulation of cholesterol transport; ISO:RGD.
DR   GO; GO:0010983; P:positive regulation of high-density lipoprotein particle clearance; ISO:RGD.
DR   GO; GO:0050746; P:regulation of lipoprotein metabolic process; ISO:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0043691; P:reverse cholesterol transport; ISO:RGD.
DR   GO; GO:0019433; P:triglyceride catabolic process; IBA:GO_Central.
DR   CDD; cd00707; Pancreat_lipase_like; 1.
DR   CDD; cd01758; PLAT_LPL; 1.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1.
DR   Gene3D; 2.60.60.20; PLAT/LH2 domain; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR013818; Lipase.
DR   InterPro; IPR016272; Lipase_LIPH.
DR   InterPro; IPR033906; Lipase_N.
DR   InterPro; IPR002330; Lipo_Lipase.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   InterPro; IPR036392; PLAT/LH2_dom_sf.
DR   InterPro; IPR000734; TAG_lipase.
DR   PANTHER; PTHR11610:SF13; ENDOTHELIAL LIPASE; 1.
DR   PANTHER; PTHR11610; LIPASE; 1.
DR   Pfam; PF00151; Lipase; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   PIRSF; PIRSF000865; Lipoprotein_lipase_LIPH; 1.
DR   PRINTS; PR00822; LIPOLIPASE.
DR   PRINTS; PR00821; TAGLIPASE.
DR   SMART; SM00308; LH2; 1.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
DR   SUPFAM; SSF49723; Lipase/lipooxygenase domain (PLAT/LH2 domain); 1.
DR   PROSITE; PS00120; LIPASE_SER; 1.
DR   PROSITE; PS50095; PLAT; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond; Glycoprotein; Heparin-binding; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..493
FT                   /note="Endothelial lipase"
FT                   /id="PRO_0000043409"
FT   DOMAIN          349..484
FT                   /note="PLAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00152"
FT   ACT_SITE        171
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        195
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10037"
FT   ACT_SITE        276
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10037"
FT   BINDING         327..339
FT                   /ligand="heparin"
FT                   /ligand_id="ChEBI:CHEBI:28304"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        67
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        82
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        395
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        66..79
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00152"
FT   DISULFID        254..274
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00152"
FT   DISULFID        299..318
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00152"
FT   DISULFID        310..313
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00152"
FT   DISULFID        465..485
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00152"
FT   CONFLICT        275..277
FT                   /note="EHE -> KHK (in Ref. 2; AAK14774/AAK14775)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   493 AA;  55924 MW;  11F8E39B2E2FCBC5 CRC64;
     MRDPVFLLGF WSLYCCFPAG SLTTLRPQGS LRDEHHKPTG VPVTITTKPS VTFNIRTSKD
     PEHEGCNLSL GDSKLLENCG FNMTAKTFFI IHGWTMSGMF ESWLHKLVSA LQTREKEANV
     VVVDWLPLAH QLYIDAVSNT RVVGRRVAGM LNWLQEKGEF SLGDVHLIGY SLGAHVAGYA
     GNFVKGTVGR ITGLDPAGPM FEGVDINRRL SPDDADFVDV LHTYTLSFGL SIGIRMPVGH
     IDIYPNGGDF QPGCGFNDVM GSFAYGTISE MVKCEHERAV HLFVDSLVNQ DKPSFAFQCT
     DPNRFKRGIC LSCRKNRCNN IGYNAKKMRK KRNSKMYLKT RAGMPFRVYH YQLKVHMFSY
     KNSGDIQPDL YITLYGSNAD SQNLPLEIVE KIELNATNTF LVYTEEYLGD LFKIRLTWEG
     VSSSWYNLWN EFRSYLSQPS SPSRELHIRR IRVKSGETQR KVAFCVQDPM KNSISPGQEL
     WFYKCQNDCR VKN
//
